Tue.Nov 14, 2023

article thumbnail

Pfizer's cost-cutting campaign hits Sandwich site in UK, where 500 workers will lose jobs

Fierce Pharma

Earlier this month, Pfizer’s $3.5 billion cost-cutting campaign crossed overseas to Ireland. Now, just a week later, Pfizer is announcing hundreds more job cuts in the U.K. | Pfizer plans to cut approximately 500 roles and ax its Pharmaceutical Sciences Small Molecule capabilities at its site in Sandwich in Kent in the U.K. The move is a consequence of Pfizer’s enterprisewide cost realignment program, which the drugmaker unveiled in mid-October.

article thumbnail

Generative AI and Patient Care: It’s All About the Content

MedCity News

Ultimately, to get generative AI in healthcare right we need input from the clinicians who will use these tools – and who understand the ramifications of applying AI without first rigorously testing applications to ensure they are safe and provide clear clinical value.

Patients 127
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

J&J and Bayer's Xarelto proves its worth across PAD subgroups in 2 new analyses

Fierce Pharma

Johnson & Johnson and Bayer’s wide-spanning VOYAGER PAD study continues to be a gold mine for proving its Xarelto’s worth in several subsets of patients with peripheral artery disease (PAD).

Patients 269
article thumbnail

Unified vision essential in UK advanced manufacturing

European Pharmaceutical Review

The Association of the British Pharmaceutical Industry (ABPI) has drawn attention to a new report , which has emphasised the importance of UK advanced manufacturing requiring a long-term strategy to ensure its continued success. This ‘manifesto for growth’, developed by the Manufacturing Five (M5), a coalition of the UK’s leading advanced trade associations, proposed the reforms necessary for the UK to close the gap with global competitors and growth of innovative manufacturing in the country.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

AstraZeneca’s Imfinzi regimen misses the mark in setback for ambitious lung cancer 2030 goal

Fierce Pharma

One study in AstraZeneca’s elaborate R&D plan for lung cancer has reached a dead end. | One study in AstraZeneca’s elaborate R&D plan for lung cancer has reached a dead end. Failure of the Imfinzi-concurrent-chemoradiotherapy regimen deals a blow to AZ’s goal to target more than half of lung cancer patients by 2030.

Patients 235
article thumbnail

Sutter Health Exec: Ditch Paternalism & Focus On The ‘Accumulation of Marginal Gains’

MedCity News

Providers must abandon paternalism and treat patients like partners in the decision-making process when drawing up care plans, according to Chris Waugh, Sutter Health’s chief design and innovation officer. Instead of prescribing a major lifestyle overhaul without considering a patient’s unique life circumstances, providers should “recognize that it’s about the tiny things and the accumulation of marginal gains,” he said.

Patients 115

More Trending

article thumbnail

USP General Chapter —Glass revised

European Pharmaceutical Review

In response to supply chain challenges, including shortages of critical glass vials for products like COVID-19 vaccines and parenteral drugs, the Packaging and Distribution Expert Committee (PD EC) has made a significant revision of United States Pharmacopeia (USP) General Chapter <660>—Glass. On 1 October 2023, the final, official version of the chapter was published.

article thumbnail

Stagnant sales for Dermavant's Vtama cast doubt on its blockbuster potential

Fierce Pharma

In the clinic, Dermavant’s nonsteroidal topical treatment Vtama is progressing nicely as recent trial results have paved the way for it to be approved for atopic dermatitis (eczema) on top of its c | In the clinic, Dermavant’s Vtama is progressing nicely as trial results have paved the way for it to be approved for atopic dermatitis (eczema) on top of its current indication for plaque psoriasis.

Sales 211
article thumbnail

Theseus Pharma Lays Off Staff, Explores Options Months After Toxicity Scuttles Lead Drug

MedCity News

Theseus Pharmaceuticals discontinued its former lead program in July following the report of dose-limiting toxicities in two patients. Though Theseus has other assets in its pipeline, it has decided to explore strategic alternatives with the goal of “maximizing shareholder value.

Leads 108
article thumbnail

FDA's oncology office uses advisory committee to spotlight timely accelerated approval confirmation

Fierce Pharma

An upcoming meeting of the FDA’s oncologic drugs advisory committee is slated to serve as a reminder for cancer drug developers that the agency is keeping a close eye on accelerated approvals. | An upcoming meeting of the FDA’s oncologic drugs advisory committee is slated to serve as a reminder for cancer drug developers that the agency is keeping a close eye on accelerated approvals.

FDA 130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Ovia Health Launches New Fertility, Family-Building Offering

MedCity News

Ovia Health unveiled a new fertility and family-building benefit for employers and health plans that includes financial support, care navigation services and one-on-one concierge support.

107
107
article thumbnail

Guide to Outsourcing 2023

European Pharmaceutical Review

Outsourcing regulatory activities in pharma Here, EPR’s Editor explores some key considerations, approaches and strategies for pharmaceutical companies looking to outsource regulatory activities. Accelerating drug development for simple and complex drug programmes Quotient Sciences leverages more than 30 years of drug development expertise to support small molecule and synthetic peptide drug programmes, in both simple drug programmes as well as complex cases where specialised formulation e

article thumbnail

Novo Nordisk to Discontinue Levemir for Diabetes Mellitus

PharmExec

Novo Nordisk said it will continue providing Levemir vials and the Levemir FlexPen for diabetes control while supplies last, until the full product discontinuation at the end of 2024.

97
article thumbnail

New acquisition to support global gene therapy manufacturing

European Pharmaceutical Review

Ajinomoto Co., Inc. is set to acquire Forge Biologics, a viral vector and plasmid contract development and manufacturing organisation (CDMO) and clinical-stage therapeutics company. According to Forge Biologics, the acquisition is an all-cash deal for $620 million, which is Forge’s enterprise value on a cash-free and debt-free basis. The equity value attributable to unitholders of Forge Biologics is approximately $554 million.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Resident Advocacy Has Changed Senior Care For the Better

MedCity News

Senior care executives have the privilege and responsibility to embrace the profound changes brought about by resident advocacy. We can champion a new era of senior care that puts the individual at the center, honoring their unique identity and aspirations.

102
102
article thumbnail

Documentary highlights new targets to potentially treat motor neurone disease

PharmaTimes

The terminal condition currently affects around 5,000 people in the UK - News - PharmaTimes

111
111
article thumbnail

Artera, Hyro Launch New AI Assistant For Providers’ Websites

MedCity News

Patient communications platform Artera teamed up with healthcare AI startup Hyro to launch a new chatbot-style assistant for providers’ websites. Using the information already available on the provider’s website, the chatbot can answer patients’ questions 24/7. Some sample questions include “What are the office hours for the radiology department?” and “Where do I park for my visit?

article thumbnail

BBSRC to invest £12m into 62 UK bioscience research projects

PharmaTimes

The projects will explore early-stage ideas at the frontiers of bioscience - News - PharmaTimes

106
106
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

AZ’s oncology hopes dented as Imfinzi flunks NSCLC trial

pharmaphorum

AZ’s oncology hopes dented as Imfinzi flunks NSCLC trial Phil.

111
111
article thumbnail

6 ways to improve clinical trial diversity — as shown by J&J

PharmaVoice

Johnson & Johnson Innovative Medicine’s director of diversity, equity and inclusion in clinical trials shares key strategies for making DEI work.

article thumbnail

AHA: First data backs AskBio’s heart failure gene therapy

pharmaphorum

AHA: First data backs AskBio’s heart failure gene therapy Phil.

104
104
article thumbnail

Ashland Launches Viatel™ Ultrapure Bioresorbable Polymers for LAIIs

PharmaTech

Dr Seán McMahon explains how Ashland’s Viatel™ bioresorbable work and rationalizes why formulators should consider using in the development of long acting injectables and implants.

52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Autifony swings $770.5m deal with Jazz for CNS drugs

pharmaphorum

Autifony swings $770.5m deal with Jazz for CNS drugs Phil.

97
article thumbnail

Expert: Digital Transformation is Key Part of Biopharma C-Suite Goals for 2024

Pharmaceutical Commerce

Stephanie L. Woerner, PhD, director and principal research scientist at the MIT Center for Information Systems Research, discusses the outlook for next year among biopharma firms.

article thumbnail

FDA oversees rise in awarded orphan drug designations for myelofibrosis

Pharmaceutical Technology

Concerns have been raised over the suitability of current FDA-approved treatments for myelofibrosis, due to the negative associations with anaemia.

FDA 59
article thumbnail

Everything You Need to Know About Medical Sales Jobs

Rep-Lite

Success in medical sales requires resilience, adaptability, and the ability to build lasting relationships with healthcare professionals. It’s a competitive field, but for those who excel, it can be a fulfilling and financially rewarding career with uncapped commission bonus opportunities. In this blog post, we’ll look at everything you need to know about medical sales jobs.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Innovative Softgel Technologies to Deliver Poorly Soluble Molecules (Nov 2023)

PharmaTech

The eBook discusses how to expedite the development pathway for early phase compounds, and how lipid based formulations provide innovative approach to enhance bioavailability for challenging molecules. It also presents how the lipid-based delivery provides a tool for highly potent, poorly soluble, and unstable APIs.

52
article thumbnail

Unlocking Oncology Insights - Innovations in Evidence Generation With RWE Solutions

PharmExec

The rapid evolvement of precision oncology requires real-world data generated at a scale that unlocks insights that can not be provided from clinical trial evidence. Custom integrated real-world evidence solutions like large language models can be used to quickly identify information to make informed decisions.

52
article thumbnail

What Is Sports Medicine Medical Sales With Jordan Rawlins

Evolve Your Success

There is no one way when it comes to medical sales. It is ripe with opportunities along with a variety of paths. One of those is sports medicine. How do you break into this field as a medical sales representative and succeed? As we celebrate International Men’s Day, Samuel Adeyinka interviews Jordan Rawlins about the world of orthopedics, namely sports medicine.

article thumbnail

Revolutionizing Field Sales: The Transformative Power Of AI In Sales

Spotio

Artificial intelligence (AI) has taken the world by storm. Professionals in a wide array of industries now use this impressive technology to organize complex data points, write text, generate visual artwork, and much more. Good news: You can also use AI to supercharge your sales career! Once you do, you’ll become more productive, make better decisions, and create better customer experiences.

Sales 52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A